Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib.
Martini DJ, Kline MR, Liu Y, Shabto JM, Carthon BC, Russler GA, Yantorni L, Hitron EE, Caulfield S, Goldman JM, Harris WB, Kucuk O, Master VA, Bilen MA. Martini DJ, et al. Among authors: caulfield s. Cancer Treat Res Commun. 2021;28:100393. doi: 10.1016/j.ctarc.2021.100393. Epub 2021 May 9. Cancer Treat Res Commun. 2021. PMID: 34029879 Free PMC article.
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
Shabto JM, Martini DJ, Liu Y, Ravindranathan D, Brown J, Hitron EE, Russler GA, Caulfield S, Kissick H, Alemozaffar M, Ogan K, Harris WB, Master VA, Kucuk O, Carthon BC, Bilen MA. Shabto JM, et al. Among authors: caulfield s. Cancer Med. 2020 Apr;9(8):2752-2760. doi: 10.1002/cam4.2932. Epub 2020 Feb 25. Cancer Med. 2020. PMID: 32100417 Free PMC article.
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Brown JT, Liu Y, Shabto JM, Martini DJ, Ravindranathan D, Hitron EE, Russler GA, Caulfield S, Yantorni LB, Joshi SS, Kissick H, Ogan K, Harris WB, Carthon BC, Kucuk O, Master VA, Bilen MA. Brown JT, et al. Among authors: caulfield s. Oncologist. 2021 May;26(5):397-405. doi: 10.1002/onco.13727. Epub 2021 Mar 18. Oncologist. 2021. PMID: 33634507 Free PMC article.
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Martini DJ, Goyal S, Liu Y, Evans ST, Olsen TA, Case K, Magod BL, Brown JT, Yantorni L, Russler GA, Caulfield S, Goldman JM, Nazha B, Harris WB, Kissick HT, Master VA, Kucuk O, Carthon BC, Bilen MA. Martini DJ, et al. Among authors: caulfield s. Oncologist. 2021 Oct;26(10):e1742-e1750. doi: 10.1002/onco.13868. Epub 2021 Jul 8. Oncologist. 2021. PMID: 34156726 Free PMC article.
Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
Olsen TA, Martini DJ, Goyal S, Liu Y, Evans ST, Magod B, Brown JT, Yantorni L, Russler GA, Caulfield S, Goldman JM, Harris WB, Kucuk O, Carthon BC, Master VA, Nazha B, Bilen MA. Olsen TA, et al. Among authors: caulfield s. Front Oncol. 2021 Jun 16;11:701345. doi: 10.3389/fonc.2021.701345. eCollection 2021. Front Oncol. 2021. PMID: 34222024 Free PMC article.
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
Martini DJ, Olsen TA, Goyal S, Liu Y, Evans ST, Magod B, Brown JT, Yantorni L, Russler GA, Caulfield S, Goldman JM, Nazha B, Kissick HT, Harris WB, Kucuk O, Carthon BC, Master VA, Bilen MA. Martini DJ, et al. Among authors: caulfield s. Front Oncol. 2021 Jul 9;11:707050. doi: 10.3389/fonc.2021.707050. eCollection 2021. Front Oncol. 2021. PMID: 34307176 Free PMC article.
41 results